Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast in Sickle Cell Anemia
NCT01960413Phase 2Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Nov 2013
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of montelukast in sickle cell anemia (SCA), sponsored by Vanderbilt University Medical Center. Started Nov 2013; status: completed.
02
Drugs
montelukast
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT01960413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01960413.